Sanofi-Aventis Starts Strong, Promises Above-Market Growth In 2005

Sanofi-Aventis' underlying growth rate is almost four percentage points stronger than the overall pharmaceutical market, the company said Oct. 21 in its first earnings report as a merged company

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet